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Abstract—Synthetic lethality (SL) is a promising concept for novel discovery of anti-cancer drug targets. However, wet-lab experiments
for detecting SLs are faced with various challenges, such as high cost, low consistency across platforms or cell lines. Therefore,
computational prediction methods are needed to address these issues. This paper proposes a novel SL prediction method, named
SL2MF, which employs logistic matrix factorization to learn latent representations of genes from the observed SL data. The probability
that two genes are likely to form SL is modeled by the linear combination of gene latent vectors. As known SL pairs are more
trustworthy than unknown pairs, we design importance weighting schemes to assign higher importance weights for known SL pairs and
lower importance weights for unknown pairs in SL2MF. Moreover, we also incorporate biological knowledge about genes from
protein-protein interaction (PPI) data and Gene Ontology (GO). In particular, we calculate the similarity between genes based on their
GO annotations and topological properties in the PPI network. Extensive experiments on the SL interaction data from SynLethDB
database have been conducted to demonstrate the effectiveness of SL2MF.
Index Terms—Synthetic lethality, machine learning, logistic matrix factorization, importance weighting, human cancers.
F
1 INTRODUCTION
A complex disease like cancer is unlikely caused by the
defect of only one gene. The understanding of genetic
interactions, therefore, is becoming more important in
cancer biology and medicine [1]. A prominent type of
genetic interaction, called synthetic lethality, has drawn
much attention in the field of cancer therapeutics [2], [3].
A pair of genes is called synthetic lethality (SL) if the
defect of a single gene will not affect the cell viability,
whereas the defects of both genes will cause cell death or
significant impairment of cell fitness. Therefore, targeting a
nonessential SL partner gene of a cancer-specific mutated
gene would selectively kill (or prohibit the proliferation
of) the cancer cells but spare normal cells. With the
availability of “omics” technologies and high-throughput
cancer genomics data, the SLs in the human genome
promise to be a gold mine for novel discovery of
anti-cancer drug targets. Indeed, both wet-lab screening
and computational data mining of SLs in the genomes of
human as well as model animal species (e.g. yeast) are under
intensive research.
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High-throughput wet-lab screenings have been
conducted to search for SLs genome-wide, using the
following technologies. First, chemical libraries are used to
identify inhibitors of gene or metabolic activities that can kill
cancer cells selectively [4]. Secondly, pooled RNAi screens
(using siRNA or shRNA libraries), which target the gene
expression at the mRNA level, have been widely adopted
for SL detection [5], [6]. Considering the complementary
strengths of the chemical and RNAi screening technologies,
the two types of technologies are sometimes integrated
into the more comprehensive approach of chemical-genetic
screening [7]. Thirdly, the emerging CRISPR-based genome
editing technology has been recently employed to screen
for essential genes and SLs [8], [9]. It is expected that this
new technology can increase the accuracy and power of
screening than the aforementioned technologies. However,
the wet-lab screenings for finding SLs are still faced with
different challenges, e.g., high cost, off-target effects, lack
of consistency across different platforms or cell lines, and
unclear mechanisms. Therefore, computational methods for
predicting SLs would be useful complements to the wet-lab
screenings.
In the literature, various computational methods have
been proposed for SL prediction in recent decade [10],
[11]. These methods can be classified into the following
three categories. The methods in the first category are in
silico knockouts in metabolic networks. As genome-wide
metabolic networks for human and model species are
available, single- and double-knockout of genes can be
simulated in these networks. By running flux-balance
analysis (FBA), the phenotypic cellular effects of these
knockouts can be estimated. Based on such metabolic
modeling, researchers have carried out predictions for
essential and SL genes in yeast [12], C.elegans [13], human
cancer cell lines [14], as well as other species [15]. The
second category refers to knowledge-based methods [16],
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2[17], [18], which predict SLs based on the knowledge or
hypotheses about SL interactions, e.g., SL genes tend to
be co-expressed, and SL genes are likely to have similar
topological properties in biological networks. For example,
network properties, e.g., graph centrality [19], network flow
[20], and connectivity homology [21], are widely explored
for SL prediction. Based on the hypotheses that SL genes
are often co-expressed and seldom co-mutated, DAISY [16]
applied three independent procedures for predicting SLs
from SCNA (somatic copy number alternation), shRNA and
gene expression profiles. Similar to DAISY, MiSL [18] also
analysed mutation, copy number and gene expression for SL
prediction. The third category includes supervised machine
learning methods that build up classification models based
on existing SL data to predict novel SL pairs. As a
large amount of SL data are available in yeast, various
classification models, e.g., decision tree [22], MLE [23], and
ensemble classifiers [24], [25], have been studied for yeast
SL prediction.
However, existing computational methods for SL
prediction have the following limitations when applied to
human cancer genome. First, existing supervised learning
methods [22], [23], [24], [25] were proposed to work on
known SL data in yeast instead of human. Without sufficient
human SL data for training the models, an alternative
way to predict SL for human is to apply the comparative
genomics approaches [11], [25], [26]. However, human and
yeast are evolutionarily distant from each other. Therefore,
the comparative analysis between human and yeast for SL
prediction may not be reliable. Secondly, knowledge-based
methods [16], [18], [19], [21] leverage on the knowledge
about the biological networks and other genomic data
(e.g., mutation and gene expression profiles). However,
they do not employ much information about underlying
mechanisms of known SL data in human.
Recently, a comprehensive database called SynLethDB
for human SLs becomes publicly available [27]. As such,
supervised learning methods can be applied on SynLethDB
for predicting human SLs. On the other hand, matrix
factorization techniques have been successfully applied
for various bioinformatics tasks, e.g., PPI prediction [28],
drug-target interaction prediction [29], and drug response
prediction [30]. Motivated by these approaches, in this
paper, we have proposed a novel matrix factorization
model, named SL2MF, for SL prediction. Differing from
existing methods for human SL prediction, SL2MF employs
logistic matrix factorization (LMF) [31] to model the
probability that a pair of genes are likely to have SL
interaction. Specifically, a latent vector is assigned to
each gene to describe its properties learnt from the data.
The probability of two genes to be SL is defined as a
logistic function of their latent vectors. To further enhance
the prediction accuracy, SL2MF has been extended to
integrate the knowledge from PPI networks and Gene
Ontology (GO) annotations. This is achieved by exploiting
neighborhood regularization to constrain that the learnt
latent vectors of genes with similar GO and/or PPI
topological properties should be similar in the latent space.
We have conducted extensive experiments to evaluate
the performance of SL2MF. The experimental results
demonstrate the effectiveness of the proposed method and
show that using the biological knowledge derived from PPI
network and GO can help improve the prediction accuracy.
In addition, the comparison between SL2MF and DAISY
also indicates that SL2MF is a useful complement to existing
knowledge-based SL prediction methods.
2 SYNTHETICAL LETHALITY PREDICTION MODEL
This section first introduces the notations and problem
formulation, and then describes details of the proposed
SL2MF model.
2.1 Preliminary
In this paper, we denote the set of genes by U = {ui}mi=1,
where m is the number of genes. Moreover, we use a binary
matrix Y ∈ Rm×m, where each element is denoted by yij ∈
{0, 1}, to describe the SL interaction data. If there exists an
observed SL interaction between two genes ui and uj , we set
yij to 1; otherwise, we set yij to 0. Note that Y is symmetric,
i.e., yij = yji. Thus, we treat the gene pairs (ui, uj) and
(uj , ui) as the same pair. Then, we denote the set of all gene
pairs by O = {(ui, uj)|1 ≤ i < m, i + 1 ≤ j ≤ m}. In
other words, we define O only considering the upper half
of Y . In addition, we denote the set of observed SL pairs by
O+ = {(ui, uj)|yij = 1, 1 ≤ i < m, i + 1 ≤ j ≤ m}. The
remaining gene pairs in the upper half of Y are denoted
by O− = O \ O+. We call the pairs in O− as “unknown
pairs”, because there does not exist evidence demonstrating
whether these gene pairs are SLs or not.
Moreover, we denote the GO semantic similarities
between genes by SG ∈ Rm×m, where the (i, j) element
sGij denotes the GO semantic similarity between ui and uj .
The PPI topological similarities between genes 1 are denoted
by SP ∈ Rm×m, where the (i, j) element sPij is the PPI
topological similarity between ui and uj . The computation
of GO semantic similarities and PPI topological similarities
are introduced in Section 3.1. For each gene ui, we use
NG(ui) to denote the set of k1 genes that are most similar
with ui, measured by the GO semantic similarities S
G,
where NG(ui) ⊂ U \ ui. Similarly, we use NP (ui) to
denote the set of k2 genes that are most similar with ui,
measured by the PPI topological similarities SP , where
NP (ui) ⊂ U \ ui. In this work, NG(ui) and NP (ui) are
called the GO nearest neighbors and PPI nearest neighbors
of ui, respectively.
The problem studied in this work can be defined as
follows: given a set of observed gene pairs O+ that are known
to be SL pairs, how to predict a set of gene pairs that are most
likely to form SL interactions from the “unknown pairs” O−.
We tackle this problem by first predicting the probability
that two genes form SL relationship, and then ranking the
candidate gene pairs based on the predicted probabilities
in descending orders, such that the top-ranked gene pairs
are most likely to be SL pairs. Specifically, the method of
logistic matrix factorization [29], [31] is utilized to model
the SL interaction probabilities between genes. Moreover,
neighborhood regularization [29] is used to incorporate both
GO semantic similarities and PPI topological similarities
1. We use genes instead of gene products (i.e., proteins) when we
mention their PPI topological similarity.
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Fig. 1: The overall framework of SL2MF.
between genes to enhance the prediction accuracy. Figure 1
shows the overall framework of the proposed SL2MF model.
2.2 Logistic Matrix Factorization
The proposed method SL2MF is developed based on logistic
matrix factorization, which has been successfully applied in
personalized music recommendation [31] and drug-target
interaction prediction [29]. The objective of logistic matrix
factorization is to map genes into a shared low dimensional
latent space and model the probabilities of SL interactions
between genes using their latent representations. For each
gene ui, a latent vector U i ∈ R1×d is used to describe its
properties, where d denotes the dimensionality of the latent
space, and d  m. We combine the latent vectors of all
genes into a matrix U ∈ Rm×d, where U i is the ith row in
U . Then, the SL interaction probability between two genes
ui and uj is defined by the following logistic function [31]:
pij =
1
1 + exp(−U iU>j )
. (1)
To model the SL data, we use the gene pairs in O+ that
have observed SL interactions as positive training examples,
and use the unknown pairs in O− as negative training
examples. Following previous study [29], we assign higher
importance weights to gene pairs that are observed SL
interactions. In other words, a known SL pair (ui, uj) ∈ O+
is treated as cij (cij > 1) positive training samples,
an unknown gene pair is used as only one negative
training sample.2 By assuming all the training samples are
independent with each other, we can define the likelihood
of the observed SL data as follows:
p(O|U) =
∏
(ui,uj)∈O+
p
cijyij
ij (1− pij)cij(1−yij)∏
(ui,uj)∈O−
p
yij
ij (1− pij)(1−yij). (2)
2. This work is not focusing on developing strategies to weight gene
pairs. Thus, we empirically set the weights based on the confidence
scores assigned to SLs in SynLethDB (see Section 3.3 for details).
Moreover, the proposed SL2MF method is a general framework which
can also integrate more sophisticated weighting methods, for example
the re-weighted probabilistic models (RPM) proposed in [32].
Note that cij(1−yij) = 1−yij when yij = 1, and yij = cijyij
when yij = 0. Thus, we can rewrite the likelihood in Eq.(2)
as follows:
p(O|U) =
m∏
i=1
m∏
j=i+1
p
cijyij
ij (1− pij)1−yij . (3)
Zero-mean spherical Gaussian priors are placed on the gene
latent vectors as follows [31]:
p(U |σ2) =
m∏
i=1
N (U i|0, σ2I), (4)
where I is the identity matrix, and σ2 is the parameter used
to control the variances of Gaussian distributions. Through
Bayesian inference, we have
p(U |O, σ2) ∝ p(O|U)p(U |σ2). (5)
The logarithm of the posterior distribution is as follows:
log p(U |O, σ2) ∝
m∑
i=1
m∑
j=i+1
[
− (1 + cijyij − yij) log
(
1 + exp(U iU
>
j )
)
+ cijyijU iU
>
j
]
− λ
2
‖U‖2F , (6)
where λ = 1σ2 , and ‖ · ‖F is the Frobenius norm of a matrix.
Then, the gene latent vectors can be learned by maximizing
the posterior distribution. It is equivalent with minimizing
the following loss function:
LO =
m∑
i=1
m∑
j=i+1
[
(1 + cijyij − yij) log
(
1 + exp(U iU
>
j )
)
− cijyijU iU>j
]
+
λ
2
‖U‖2F . (7)
2.3 Incorporating Gene Similarities
As mentioned earlier, two types of gene similarities, i.e.,
GO semantic similarities and PPI topological similarities, are
considered to improve the prediction accuracy. Specifically,
we assume that genes with similar functional and/or
network properties should have similar representations
in the latent space. Then, we propose to minimize
the following loss function to exploit the GO semantic
similarities between genes for SL prediction:
LG =
1
2
m∑
i=1
∑
uj∈NG(ui)
sGij‖U i −U j‖22. (8)
Similarly, the PPI similarities between genes can also be
incorporated by minimizing the following loss function:
LP =
1
2
m∑
i=1
∑
uj∈NP (ui)
sPij‖U i −U j‖22. (9)
Note that the proposed method only considers k1 GO
nearest neighbors and k2 PPI nearest neighbors of each gene
ui, instead of all its neighbors (i.e., U \ ui), to improve the
prediction accuracy. Because using all the neighbors may
potentially introduce noisy information and thus reduce
the model accuracy. In addition, the experimental results
in Section 3.4 also demonstrate that better performance can
be achieved by considering only the nearest neighbors of a
gene than considering all of its neighbors.
4Algorithm 1: The SL2MF Algorithm
Input : Y , W , SG, SP , d, λ, α, β, γ, k1, k2
Output: U
1 Initialize gene latent vectors U using the Gaussian
distribution N (0, 1/√d);
2 Compute the adjacency matrix A and the Laplacian
matrix LG according to Eq. (11);
3 Compute the adjacency matrix B and the Laplacian
matrix LP according to Eq. (13);
4 Set ϕik = 0, ∀1 ≤ i ≤ m and 1 ≤ k ≤ d;
5 for iter = 1, 2, · · · ,max iter do
6 Compute the interaction probability matrix P
according to Eq. (1);
// compute the gradient w.r.t. U
7 Z ← [W  (P − Y ) + λI + αLG + βLP ]U ;
8 for i = 1, . . . ,m do
9 for k = 1, . . . , d do
// Zik is the (i, k) element in Z
10 ϕik ← ϕik + Zik · Zik;
// Uik is the (i, k) element in U
11 Uik ← Uik − γ Zik√ϕik ;
2.4 The Unified SL2MF Model
The final prediction model can be formulated by considering
the SL interaction data as well as both GO semantic
similarities and PPI topological similarities between genes.
By substituting Eq. (8) and Eq. (9) into Eq. (7), the unified
SL2MF model is obtained as follows:
min
U
LO + αLG + βLP , (10)
where α and β are regularization parameters controlling
the influences from GO nearest neighbors and PPI nearest
neighbors, respectively.
For simplicity, we define two adjacency matrices A ∈
Rm×m and B ∈ Rm×m to describe the nearest neighbors of
genes. The (i, j) element of A is defined as follows:
aij =
{
sGij if uj ∈ NG(ui),
0 otherwise.
(11)
Then, the loss function LG can be rewritten as follows:
LG =
1
2
tr(U>LGU), (12)
where tr(·) denotes the trace of a matrix, LG = DG −
(A + A>), DG ∈ Rm×m is a diagonal matrix, in which
the diagonal elements are defined as dGii =
∑m
j=1(aij + aji).
Similarly, the (i, j) element of B is defined as follows:
bij =
{
sPij if uj ∈ NP (ui),
0 otherwise.
(13)
We can rewrite the loss function LP as follows:
LP =
1
2
tr(U>LPU), (14)
where LP = DP − (B +B>). DP ∈ Rm×m is a diagonal
matrix, in which the diagonal elements are defined as dPii =
∑m
j=1(bij + bji). Then, the unified model in Eq. (10) can be
rewritten as follows:
min
U
1
2
m∑
i=1
m∑
j=1
wij
[
log
(
1 + exp(U iU
>
j )
)− yijU iU>j ]
+
λ
2
‖U‖2F +
α
2
tr(U>LGU) +
β
2
tr(U>LPU), (15)
where wij is defined as follows:
wij =

cij if yij = 1 and i 6= j,
1 if yij = 0 and i 6= j,
0 if i = j.
(16)
Note that yij = yji and cij = cji, thus wij = wji.
The problem in Eq. (15), denoted by L, can be solved by
the gradient descent optimization procedure. The gradient
of Eq. (15) with respect to U is as follows:
∂L
∂U
=
[
W  (P − Y ) + λI + αLG + βLP ]U , (17)
where  is the Hadamard product of two matrices. W ∈
Rm×m is the weighting matrix, where the (i, j) element
is wij (refer to Eq. (16)). P ∈ Rm×m is the interaction
probability matrix, in which the (i, j) element is pij
(refer to Eq. (1)). Following [31], we adopt the AdaGrad
algorithm [33] to accelerate the convergence of the gradient
descent procedure. The details of the optimization algorithm
developed for SL2MF are summarized in Algorithm 1.
Once having learned the model parameters U , Eq (1)
is used to compute the probability that a candidate pair
of genes are SL. Then, all candidate gene pairs O− are
ranked based on the predicted probabilities in descending
orders, and the top-ranked gene pairs will be chosen as the
predictions.
2.5 Discussions
As shown in Eq. (10) and Eq. (15), the unified model
is a linear combination of the optimization problem in
Eq. (7) and the neighborhood regularization constraints
Eq. (8) and Eq. (9). Therefore, the construction of the
unified model does not fully follow the spirit of probabilistic
models. However, inspired by previous research work about
social recommendation [34], we can note that the usage
of the regularization terms λ2 ‖U‖2F + α2 tr(U>LGU) +
β
2 tr(U
>LPU) in Eq. (15) is equivalent to assigning the
following priors on the gene latent vectors U :
p(U |LG,LP , λ, α, β) ∝
MNm×d
(
0, (λI + αLG + βLP )−1, I
)
, (18)
whereMNa×b(M ,Σ,Θ) is a matrix variate normal (MVN)
distribution3 [35] with the meanM ∈ Ra×b, row covariance
Σ ∈ Ra×a, and column covariance Θ ∈ Rb×b. In Eq. (18), the
relations between different rows of U are described by the
row precision matrix: Ω = λI+αLG+βLP . Note that each
3. The density function for a random matrix X following the MVN
distributionMNa×b(M ,Σ,Θ) is as follows:
p(X) =
exp(− 1
2
tr
[
Θ−1(X −M)>Σ−1(X −M)])
(2pi)ab/2|Θ|a/2|Σ|b/2 .
5row of U denotes the latent vector of an individual gene.
Therefore, in other words, the relations between different
genes are modeled by the row precision matrix Ω. Through
Bayesian inference, we have
p(U |O,LG,LP , λ, α, β) ∝ p(O|U)p(U |LG,LP , λ, α, β).
(19)
The gene latent vectorsU can be learned by maximizing the
above posterior distribution, which is equivalent to solving
the optimization problem in Eq. (15).
3 RESULTS
In this section, we first introduce the data used in the
experiments and the experimental settings. Then, we show
the performances of SL2MF under different settings.
3.1 Data and Experimental Settings
The proposed SL2MF method works on the SL interaction
matrix and various gene similarity matrices, including PPI
topological similarity matrix and GO semantic similarity
matrix. The SL dataset was downloaded from the database
of SynLethDB [27]. SynLethDB integrates SL interaction
data from four different sources: (1) SL pairs manually
curated [36], (2) SL pairs extracted by text mining [27],
(3) genetic interactions detected by GenomeRNAi [37] and
shRNA (i.e., the DECIPHER project4), and (4) SL pairs
computationally predicted by DAISY [16]. Overall, there
are 19,667 SL pairs involving 6,375 genes in the SL matrix.
The sparsity of the SL interaction matrix is 99.90%, thus
the SL prediction is a very challenging prediction task.
In SynLethDB, a confidence score is assigned to each SL
pair, considering the accuracies of different identification
methods. These confidence scores have been exploited to
define the weights assigned to SL pairs in SL2MF (refer to
Table 2 for details). Moreover, we downloaded the HPRD
database [38] to construct the PPI topological similarity
matrix. FSWeight [39], which is a topological similarity
between genes based on the number of common neighbors
in the PPI data, was then calculated. Among various
methods for computing the GO term similarity, we used
the method proposed in [40] and then calculated the GO
semantic similarity between genes. It is known that GO
has three sub-ontologies, namely biological process (BP),
molecular function (MF) and cellular component (CC). In
GO (version: June 2017), there are 29,660 terms in BP, 11,120
terms in MF, and 4,115 terms in CC, respectively. BP has
many more terms and are more enriched than MF and CC.
Therefore, we computed the semantic similarity between
genes only using their BP terms.
In our experiments, we adopted 5-fold cross-validation
to evaluate the proposed method. The known SL pairs P
in SynLethDB were equally divided into 5 non-overlapping
subsets (i.e., P1, P2, P3, P4, P5). In each round, a subset
Pi(1 ≤ i ≤ 5) of SL interactions were chosen for model
testing, and the other four subsets were used as positive
examples for model training (i.e., O+). The objective of
SL2MF is to predict the potential SL pairs in O− (i.e., Pi)
via ranking the gene pairs in Pi before other gene pairs in
4. http://www.decipherproject.net/shRNA-libraries/bi-specific/
TABLE 1: The 5-fold cross-validation AUC and AUPR scores
of BLM-NII and SL2MF with respect to different settings.
Method AUC AUPR
BLM-NII 0.7228±0.0293 0.0011±0.0010
SL Matrix 0.8051±0.0060 0.2081±0.0072
SL+PPI 0.8330±0.0029 0.1326±0.0046
SL+GO 0.8437±0.0049 0.2414±0.0062
SL+PPI+GO 0.8480±0.0048 0.2388±0.0057
O−. Therefore, we use AUC (i.e., area under the ROC curve)
and AUPR (i.e. area under the precision-recall curve) as
evaluation metrics. In particular, the AUC and AUPR scores
were calculated based on the predictions of all candidate
gene-gene pairs.
The proposed SL prediction model is built based on
the known SL interaction data in human, the GO semantic
similarities and PPI topological similarities between genes.
Therefore, existing supervised learning methods [22], [23],
[24], [25] for yeast SL prediction and other knowledge-based
methods [16], [18], [19], [21] for human SL prediction
cannot be directly used as baselines in this study. As SL
prediction shares similar spirits with drug-target interaction
prediction [29], we adopt the similarity-based drug-target
interaction prediction method BLM-NII [41] as the baseline
method. In BLM-NII, the linear combination weight α was
chosen from {0, 0.1, 0.2, · · · , 1.0}, and the max function
was used to integrate the interaction scores predicted
independently by using the GO semantic similarities and
the PPI topological similarities. For SL2MF, we empirically
set the dimensionality of latent space d to 50. We assigned
uniform weights to SL pairs as shown in Table 2, and the
parameter c was set to 50. The regularization parameters λ,
α, and β were set to 0.01, 1.0, and 10, respectively. The
learning rate γ of the optimization algorithm was set to
2−5. The number of GO semantic nearest neighbors and PPI
topological nearest neighbors k1 and k2 were set to 100. In
Section 3.4, we will discuss the impacts of these parameters.
3.2 5-fold Cross Validation Results
Table 1 shows the AUC and AUPR scores of BLM-NII
and SL2MF with respect to different inputs. In Table 1,
“SL Matrix” refers to SL2MF without using any similarity
matrices, “SL+PPI” refers to SL2MF incorporating only the
PPI topological similarity matrix via setting the parameter α
to 0 in Eq. (15), and “SL+GO” refers to SL2MF incorporating
only the GO semantic similarity matrix by setting β to 0.
Similarly, “SL+PPI+GO” indicates that SL2MF works on SL
matrix together with both the PPI topological similarity
matrix and the GO semantic similarity matrix. Based on
the results in Table 1, we can draw the following two
conclusions.
First, both PPI topological similarities and GO
similarities can help improve the performance for predicting
SL interactions, in terms of AUC. For example, the
AUC scores are improved by 3.47% and 4.79% after
incorporating the PPI topological similarities and GO
similarities, respectively. Moreover, the GO similarities can
also help improve AUPR scores. However, by incorporating
the PPI similarities into the model, AUPR scores are
dropped off. This is to be expected, since the strategy
6TABLE 2: Different definitions of the importance weights
assigned to SL pairs. Here εij is the confidence score of each
SL pair in SynLethDB [27].
Definitions
Uniform Weights cij = c
Linear Weights cij = 1 + cεij
Loglinear Weights cij = 1 + c log(1 + εij)
used to improve AUC scores is not guaranteed to improve
AUPR scores, and also because AUPR punishes highly
ranked false positives much more than AUC [42]. One
potential explanation for this observation is as follows.
When incorporating PPIs, less non-SL gene pairs are ranked
before SL gene pairs, thus increasing AUC. However, these
falsely ranked non-SL gene pairs may be ranked at higher
positions, thus decreasing AUPR.
Secondly, the GO semantic similarity matrix performs
better than the PPI topological similarity matrix in
improving the prediction accuracy. Compared with the PPI
topological similarity matrix, the GO semantic similarity
matrix is able to further improve the AUC and AUPR by
1.28% and 82.05%, respectively. One reason could be that the
PPI topological similarity matrix is much sparser than the
GO semantic similarity matrix. In particular, the sparsity of
the PPI topological similarity matrix SP and GO semantic
similarity matrix SG are 98.65% and 17.04%, respectively.
The sparsity is defined as the percentage of zero elements in
the matrix.
Thirdly, as shown in Table 1, we can notice that
the proposed SL2MF method significantly outperforms
BLM-NII, in terms of AUC and AUPR, and the AUPR score
achieved by BLM-NII is around 0.001. The potential reason
is that both similarity matrices SG and SP are sparse.
Thus, BLM-NII cannot exploit enough gene similarities
for accurate SL prediction. In addition, this result also
demonstrates the effectiveness of SL2MF in handling sparse
information for SL prediction.
3.3 Benefits of Importance Weights
The SL pairs collected in SynLethDB are usually supported
by different types of evidences. They are more trustworthy
and important than the unknown pairs. Hence, we design
a parameter cij in Eq. (3) to control the importance levels
for known SL pairs. In particular, each SL pair is treated
as cij positive training instances while each unknown pair
is treated as a single negative instance. In this paper, we
have studied three different definitions of the importance
weights cij assigned to SL pairs based on the confidence
scores defined in SynLethDB [27], as shown in Table 2.
Figure 2 shows the performances of the proposed SL2MF
method with respect to different settings of cij . As shown
in Figure 2, better performances can usually be achieved
by assigning uniform weights to SL pairs. This observation
is to be expected. Because the calculation of AUC and
AUPR scores does not consider the quality of the SL pairs.
Uniform weights may achieve better performance than
linear weights and log-linear weights, in terms of AUC
and AUPR. Moreover, the confidence scores provided in
SynLethDB are empirically set by the authors of SynLethDB.
These scores may not be optimal for SL prediction tasks. For
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Fig. 2: The AUC and AUPR scores of SL2MF with different
definitions of the weight cij for “SL+GO+PPI”.
uniform weights, when c is set to 1 (i.e., known SL pairs
are equally important as unknown pairs), the performance
of SL2MF is poor, i.e., the AUC is only 0.5119. When
we increase the value of c, the performance of SL2MF is
significantly improved. However, when c is large enough
(e.g., c > 50), the performance of SL2MF becomes stable. As
such, we recommend that 50 is a proper setting for c when
predicting SL interactions by incorporating both similarities.
3.4 Parameter Sensitivity Analysis
This sections focuses on sensitivity analysis for parameters
d, α, β, λ, k1, and k2. Note that we use SL matrix and both
similarity matrices (i.e., “SL+GO+PPI”) to show the effects of
parameters d, α, and β. For parameters k1 and k2, we show
their settings for “SL+PPI” and “SL+GO”, respectively.
Parameter d is the dimensionality of the learned
latent vectors of genes. As shown in Figure 3 (a), AUC
becomes stable when d ≥ 30. Moreover, AUPR generally
improves with the increase of d. However, larger d
causes more computation time used to learn gene latent
vectors. Considering both the efficiency and accuracy, we
empirically set d to 50 in this study. Parameters α and β
are coefficients controlling contributions of GO semantic
similarity matrix and PPI topological similarity matrix,
respectively. Figures 3 (c) and 3 (d) show AUC and AUPR
scores of proposed method with respect to different settings
of α, by fixing β to 10. We can observe that the optimal value
for α is 1. In Figures 3 (e) and (f), we fix α to 1 and then
vary the values of β. We can observe that both AUC and
AUPR are consistently high when β ∈ [0.0001, 10], but they
are decreased when β is further increased to 100 and 1000.
Gradually decreasing β from 10 to 0.0001 will not affect the
performance, indicating that the PPI topological similarity
matrix has less impact on the performance than the GO
semantic similarity matrix. This result is also consistent with
Table 1, where “SL+GO” performs better than “SL+PPI”.
Moreover, Figures (g) and (f) summarize the performances
with respect to different settings of λ. We can notice that
both AUC and AUPR are very stable when λ ∈ [0.0001, 10].
However, when λ is further increased, AUC is dramatically
decreased and AUPR is slightly increased.
Parameters k1 and k2 are the numbers of nearest
neighbors used in regularization constraints Eq. (8) and
Eq. (9). For “SL+GO”, it is clear that the optimal value of
k1 is 150 as shown in Figures 4 (a) and (b). For “SL+PPI”,
the number of nearest neighbors utilized by regularization
is supposed to be small, due to the high sparsity of the PPI
topological similarity matrix. Figure 4 (c), where the optimal
value of k2 is 10, also confirms this supposition. Overall, the
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Fig. 4: Impacts of k1 for “SL+GO” and k2 for “SL+PPI”.
recommended settings of parameters k1 and k2 are 150 and
10 for “SL+GO” and “SL+PPI”, respectively. Moreover, the
rightmost points in Figure 4 refer to AUC and AUPR scores
using “All” the neighbors (i.e., 6,374 neighbors). Therefore,
better performances can be achieved by exploiting only a
few nearest neighbors instead of all the neighbors.
3.5 Comparison with DAISY
As mentioned earlier, SL2MF is a supervised matrix
factorization model, whereas DAISY [16] is a well-known
knowledge-based method for SL prediction which is based
on three hypotheses about SL gene pairs. More importantly,
we have conducted experiments and obtained all the results
above using the whole SynLethDB dataset comprising
19,667 SL pairs, including 5,740 SL pairs predicted by
DAISY. To fairly compare the predictions of SL2MF with
those of DAISY, we modify the data setting for SL2MF as
follows.
We first remove the SL pairs predicted by DAISY from
SynLethDB. Then, we also reserve a validation set consisting
of SL pairs with high reliability (e.g., high confidence
scores in SynLethDB). After excluding these two parts, the
remaining SL pairs in SynLethDB will be used as positive
training samples to train SL2MF. In particular, we have
worked on two scenarios for comparing SL2MF and DAISY
as shown in Figure 5. In scenario 1, the manually curated
SL pairs (i.e., the SynLethality database [36] which is also
the part of SynLethDB with the highest confidence scores)
are used as validation set. In scenario 2, the validation set is
expanded by further including those SL pairs extracted by
text mining [27].
Once completing the model training of SL2MF,
the candidate SLs are ranked based on the predicted
probabilities. The validation AUC scores of SL2MF are
0.7330 in scenario 1 and 0.6701 in scenario 2. The AUC score
in scenario 2 is relatively lower, probably because less SL
pairs are used to train SL2MF in the second scenario, which
might affect the performance of the trained SL2MF model.
However, in both scenarios, the validation AUPR scores
of SL2MF are less than 0.005. One potential reason is that
AUPR punishes highly ranked false positives much more
than AUC [42], and the validation SLs do not rank high
based on the interaction probabilities predicted by SL2MF.
Moreover, we have also studied the top 5,740 SL pairs
(i.e., the same size of DAISY) predicted by SL2MF. In the
first scenario, 14 out of 5,740 pairs predicted by SL2MF
are also in the SynLethality database, while DAISY has no
overlap with SynLethality database. In the second scenario,
27 out of 5,740 pairs predicted SL2MF are verified by
the validation set (i.e., SynLethality + Text Mining), while
only 3 SL pairs in DAISY are verified by text mining. In
addition, we also observed that SL2MF and DAISY have
limited overlap in their predictions. In scenario 1, they
have only 5 predicted SL pairs in common: (POLR2A,
WRAP53), (PARP1, PRKDC), (EGFR, IGFBP3), (POLD1,
POLR2A), (CHEK1, MRE11); in scenario 2, only 3 SL
pairs are commonly predicted by both methods: (POLR2A,
WRAP53), (EGFR, IGFBP3), (POLD1, POLR2A). Such a
small overlap actually makes sense as SL2MF and DAISY
have different prediction mechanisms and use different data
sources for prediction. For example, in scenario 1, the 5,740
SL pairs predicted by SL2MF correspond to 3,555 genes.
Meanwhile, the 5,740 SL pairs predicted by DAISY involve
3,796 genes. However, there are only 998 genes covered by
both DAISY and SL2MF predictions. Given SL2MF’s good
performance evaluated by cross validation, we believe that
SL2MF is a useful complement to the existing methods, such
as DAISY.
81215,740 
13,806
DAISY Validation set:
SynLethality
SL
2MF’s Training Data
1,254
5,740 
12,676
DAISY
Validation set:
SynLethality+
Text Mining
SL
2MF’s Training Data
(1) Scenario 1                                        (2) Scenario 2
Fig. 5: Two different scenarios to run SL2MF for comparison
with DAISY. The set of SLs predicted by DAISY and the
validation SL set have no overlap in scenario 1, and these
two sets have 3 common SL pairs in scenario 2. Both
scenarios have 19,667 SL pairs.
4 CONCLUSION AND FUTURE WORK
In this paper, we have proposed a novel method for
predicting the genetic interactions of synthetic lethality,
named SL2MF, which exploits logistic matrix factorization
to model the probability that two genes are likely to
form synthetic lethality. Because the observed SL pairs are
supported by different types of evidence, we proposed to
assign higher importance weights to known SL pairs, and
assigned lower importance weights to other gene pairs.
To further enhance the prediction accuracy of SL2MF,
we integrated both GO semantic similarities and PPI
topological similarities between genes into learning gene
latent vectors. Extensive experiments have been performed
to evaluate the prediction accuracies of SL2MF, under
different settings. Experimental results have shown that
SL2MF is able to achieve promising performance for SL
prediction. We believe that it can serve as a good baseline
for future studies on this topic.
The future work will focus on the following directions.
First, we plan to integrate more sophisticated weighting
method, e.g., the re-weighted probabilistic model (RPM)
proposed in [32], to improve the prediction accuracy of
SL2MF. Moreover, the lack of a nice independent validation
dataset, which covers all required information of various
methods, to compare SL2MF with existing SL prediction
methods is a weakness of this work. To address this issue,
it will be a highly desirable future work to expand the
current version of SynLethDB database to incorporate SLs
identified by siRNA/CRISPR based knockdown screens or
other existing methods. Furthermore, we also would like to
integrate more types of data (e.g., protein domains, TCGA
data) to further improve SL2MF’s performance. As more
data are processed, we can also investigate feature-based
classification models (e.g., Gradient Boosting Machines
[43]) for SL prediction. Last but not least, verifying the
effectiveness of SL2MF through wet-lab experiments is also
a potential research direction for future work.
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